CLINICAL RESEARCH FORUM INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

ANDREA VAN HOOK

Phone

2023671176

Tax Period

2024-01-01 to 2024-12-31

CLINICAL RESEARCH FORUM INC, founded in 2005, is a small nonprofit in the Science & Technology sector that reported $472K in total revenue in fiscal year 2024.

Mission

TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE.

Program Service Accomplishments

Program 1

Expenses: $151,701

TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS - THE TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS HONOR OUTSTANDING ACCOMPLISHMENTS AND MAJOR ADVANCES RESULTING FROM THE NATION'S INVESTMENT IN RESEARCH...

Program 2

Expenses: $49,702 Revenue: $408,500

MEMBERSHIP - THE MEMBERSHIP SERVICES INCLUDES DUES INVOICING AND PROCESSING AND DATABASE UPDATES OF ORGANIZATIONAL MEMBERS AND THEIR TEAMS SO THAT THEY CAN ACCESS THEIR BENEFITS, REGISTER FOR EVENTS...

Program 3

Expenses: $44,999

ADVOCACY - THE COALITION FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) IS THE UNIFIED VOICE OF THE CLINICAL AND TRANSLATIONAL SCIENCE RESEARCH COMMUNITY, OF WHICH THE CLINICAL RESEARCH FORUM IS A...

ADVOCACY - THE COALITION FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) IS THE UNIFIED VOICE OF THE CLINICAL AND TRANSLATIONAL SCIENCE RESEARCH COMMUNITY, OF WHICH THE CLINICAL RESEARCH FORUM IS A MEMBER. STARTED AS A COALITION OF ORGANIZATIONS WITH A SHARED MISSION TO SUPPORT CLINICAL AND TRANSLATIONAL SCIENCE, CCTS HAS GROWN INTO A NATIONWIDE GRASSROOTS NETWORK OF DEDICATED INDIVIDUALS WHO WORK TOGETHER TO EDUCATE CONGRESS AND THE ADMINISTRATION ABOUT THE VALUE AND IMPORTANCE OF FEDERAL CLINICAL AND TRANSLATIONAL RESEARCH AND RESEARCH TRAINING AND CAREER DEVELOPMENT ACTIVITIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $32,500

Program Service Revenue $417,582

Investment Income $22,084

Other Revenue $0

TOTAL REVENUE $472,166

Expense Breakdown

Grants Paid $17,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $279,855

Other Expenses $474,411

TOTAL EXPENSES $491,911

Year-over-Year Comparison

	2024	2023	Change
Revenue	$472,166	$465,518	+0.0%
Expenses	$491,911	$546,216	-0.1%
Net Income	$-19,745	$-80,698	-0.8%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HARRY P SELKER MD MSPH	CHAIR	1.00	Officer Director	$0	$0	$0
HERBERT PARDES MD	VICE-CHAIR UNTIL APRIL	1.00	Officer Director	$0	$0	$0
WILLIAM L LOWE JR MD	SECRETARY/TREASURER	1.00	Officer Director	$0	$0	$0
EMMA MEAGHER MD	DIRECTOR UNTIL MAY, THEN VICE CHAIR	1.00	Officer Director	$0	$0	$0
E ALBERT REECE MD PHD MBA	DIRECTOR UNTIL MAY, THEN VICE CHAIR	1.00	Officer Director	$0	$0	$0
BARRY S COLLER MD	DIRECTOR	1.00	Director	$0	$0	$0
ANNE B CURTIS MD	DIRECTOR	1.00	Director	$0	$0	$0
PAMELA DAVIS MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
MAURIZIO FAVA MD	DIRECTOR	1.00	Director	$0	$0	$0
HARRY B GREENBERG MD	DIRECTOR	1.00	Director	$0	$0	$0
RACHEL HESS MD MS	DIRECTOR	1.00	Director	$0	$0	$0
RAINU KAUSHAL MD	DIRECTOR	1.00	Director	$0	$0	$0
ARTHUR H RUBENSTEIN MBBCH	DIRECTOR	1.00	Director	$0	$0	$0
ANANTHA SHEKHAR MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
DUANE MITCHELL MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
GARY ELLIOT ROSENTHAL MD FACP	DIRECTOR AS OF JULY	1.00	Director	$0	$0	$0
SHARON M MOE MD	DIRECTOR AS OF JULY	1.00	Director	$0	$0	$0
ANDREA VAN HOOK	EXECUTIVE DIRECTOR	15.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$472,166	$491,911	$1,125,533	$-19,745
2023	$465,518	$546,216	$1,080,307	$-80,698
2022	$425,166	$439,526	$950,176	$-14,360
2021	$437,799	$393,898	$1,157,797	$43,901
2020	$443,102	$388,758	$1,032,436	$54,344
2019	$470,217	$453,839	$922,837	$16,378
2018	$397,289	$478,873	$1,048,191	$-81,584